---
schema_version: "secwatch.filing_event.v1"
accession: "0001846253-23-000024"
form_type: "8-K"
ticker: "OABI"
cik: "0001846253"
company_name: "OmniAb, Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:41:19.846406+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OmniAb Q4 revenue $35.3M, net income $6.8M; record 13 new partnerships in 2022

## Summary
- Q4 revenue $35.3M (up from $15.3M YoY) driven by $25M TECVAYLI milestone; net income $6.8M vs loss of $3.1M.
- Full year 2022 revenue $59.1M (up from $34.7M); net loss $22.3M ($0.26/share) vs $27.0M loss in 2021.
- Cash and short-term investments $88.3M at Dec 31, 2022; received additional $35M in Jan 2023 from Janssen.
- Signed 13 new licenses in 2022; 26 OmniAb-derived programs in clinic/commercial; 291 total programs.
- Expects $10M milestone from TECVAYLI EU approval in 2023; 2023 year-end cash slightly higher than 2022.

## SEC filing metadata
- accession: 0001846253-23-000024
- form_type: 8-K
- ticker: OABI
- cik: 0001846253
- company_name: OmniAb, Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1846253/000184625323000024/0001846253-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1846253/000184625323000024/lgnd-20230330.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001846253-23-000024
- JSON: https://secwatch.observer/filing/0001846253-23-000024.json
- Plain text: https://secwatch.observer/filing/0001846253-23-000024.txt

## Key facts
- Earnings Releases
  OmniAb, Inc. reported financial results for three months and full year ended December 31, 2022.
  - Period: three months and full year ended December 31, 2022
  - Result: reported results
  source text: On March 30, 2023, OmniAb Incorporated (the “Company”) issued a press release announcing its financial results for the three months and full year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1846253/000184625323000024/0001846253-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.